Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 30;59(1):92-100.
doi: 10.1007/s43465-024-01305-1. eCollection 2025 Jan.

Obese Patients Do Not Benefit from Bone Marrow Aspiration Concentrate Injection for Knee Osteoarthritis: A Prospective Cohort Study of 68 Patients

Sathish Muthu  1   2 , Praveen Thangavel  3 , Sivaraman Duraisamy  3 , Saurabh Kumar Jha  1   4 , Karthikraja Ramanathan  2 , Sangilimuthu Alagar Yadav  5 , Rajni Ranjan  6
Affiliations

Obese Patients Do Not Benefit from Bone Marrow Aspiration Concentrate Injection for Knee Osteoarthritis: A Prospective Cohort Study of 68 Patients

Sathish Muthu et al. Indian J Orthop. .

Abstract

Background: Bone marrow aspirate concentrate (BMAC) is considered one of the biological treatments for knee osteoarthritis (KOA). Patient selection remains a key factor to ensure that optimal treatment benefit and body mass index (BMI) are one of the key factors to be considered. This study aims to evaluate the influence of obesity on the duration of treatment benefit of BMAC for KOA.

Methods: This prospective cohort study enrolled 68 patients who underwent a single BMAC injection for early stage KOA. The patients were categorized based on their BMI into normal, overweight, and obese groups. Visual Analog Scale (VAS) for pain and Knee Injury and Osteoarthritis Outcome Score (KOOS) were the outcomes analysed. The duration of treatment benefit is estimated by Kaplan-Meier survival analysis.

Results: Sixty-eight patients (normal BMI = 43, overweight BMI = 15, obese BMI = 10) were enrolled in the study for analysis. While significant improvement in the outcome scores was noted compared to the baseline throughout the study period in the normal BMI and overweight group, the obese group returned to baseline parameters at 3 months follow-up. Patients in the normal BMI group demonstrated significant improvement in VAS (p < 0.001) and KOOS (p < 0.001) outcomes compared to the overweight and obese group. Survival analysis demonstrated a significant decline in the mean treatment benefit of 9.8 (95%CI [6.151-13.431], p = 0.027) months in normal BMI group to 6.6 (95%CI [3.473-9.727]) months and 4.1 (95%CI [2.760-5.440]) months in overweight and obese groups, respectively.

Conclusion: BMI is a significant factor that influences the benefit of BMAC injection for early knee OA. Hence, BMAC injection must be used with caution in individuals with high BMI.

Keywords: BMAC; BMI; Body mass index; Bone marrow aspirate concentrate; Obese; Overweight.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that there are no competing interests.

Similar articles

See all similar articles

References

    1. Muthu, S. (2023). Osteoarthritis, an old wine in a new bottle! World Journal of Orthopedics,14(1), 1–5. 10.5312/wjo.v14.i1.1 - PMC - PubMed
    1. Laver, L., Filardo, G., Sanchez, M., Magalon, J., Tischer, T., Abat, F., et al. (2024). The use of injectable orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus Part 1-Blood-derived products (platelet-rich plasma). Knee Surgery, Sports Traumatology, Arthroscopy: Official Journal of the ESSKA,32(4), 783–797. 10.1002/ksa.12077 - PubMed
    1. Muthu, S., Saravanakumar, T. P., Ganie, P. A., Yadav, V., Baghel, P. K., & Jeyaraman, M. (2022). Thematic trend mapping and hotspot analysis in bone marrow aspirate concentrate therapy: a scientometric literature analysis and advances in osteoarthritis. Cytotherapy,24(5), 445–455. 10.1016/j.jcyt.2022.01.002 - PubMed
    1. Muthu, S., Jeyaraman, M., Narula, A., Ravi, V. R., Gandi, A., Khanna, M., et al. (2023). Factors influencing the yield of progenitor cells in bone marrow aspiration concentrate-a retrospective analysis of 58 patients. Biomedicines,11(3), 738. 10.3390/biomedicines11030738 - PMC - PubMed
    1. Kyriakidis, T., Pitsilos, C., Iosifidou, M., Tzaveas, A., Gigis, I., Ditsios, K., et al. (2023). Stem cells for the treatment of early to moderate osteoarthritis of the knee: a systematic review. Journal of Experimental Orthopaedics,10(1), 102. 10.1186/s40634-023-00665-1 - PMC - PubMed